Next years Workshops will be announced in January 2015
BIO World Congress on Industrial Biotechnology workshops are designed for specific and focused discussions on business or technical information. Email Sara Morgenstern, email@example.com  for more information on presenting at the 2015 World Congress.
Workshops are open to all attendees with a full conference registration!
Misters Riedy, Kirkwood, and May will discuss available debt, equity and non-dilutive funding sources and mechanisms for renewable chemicals and bioenergy technology companies and their US and international projects, including the use of credit enhanced debt; protective insurance products; strategic investor equity; non-dilutive grants and tax equity; regulatory incentives; capital and institutional markets; green funds from states and banks; and new capital equity expansion mechanisms such as MLPs, REITs, High Yield Bond Funds, Yieldcos and other hybrid structures.
The renewable chemical sector is rapidly growing as a result of numerous drivers including new and continuously improving technology, consumer demand, regulatory changes, material shortages, and most importantly, market pull from brand owners. Succinity™, a joint venture between BASF and Corbion Purac, is pleased to present a panel of speakers who are actively pursuing the commercialization of renewable commodity and specialty chemicals from biomass. The panelists will discuss business strategies, product development, market development, and new opportunities as a result of providing a more sustainable offering for the introduction of petrochemical alternatives. The four panelists will present a broad array of renewable chemicals that provide solutions for multiple applications and markets, including packaging, coatings, adhesives, household products, and electronics. These renewable chemicals include succinic acid, (Succinity), lactides (Corbion Purac), 1,4-butanediol (BASF) and itaconic acid (Itaconix Corporation).
Highlighting the Amyris Brazil-U.S. model, the workshop will discuss collaborations between the U.S. and Brazil and discuss various licensing and IP opportunities and challenges for such international collaborations. The audience will be invited to discuss with the panelists U.S. – Brazil relationships, roadblocks, and opportunities to commercialize the next wave of biotech research.